Answers are grounded in this paper and cite their sources.
The trafficking of hematopoietic stem and progenitor cells (HSPCs) is central to hematopoietic homeostasis, mobilization, and transplantation, yet its in vivo dynamics remain incompletely understood. Using serial intravascular staining (SIVS) in rhesus macaques, we mapped CD34⁺ HSPC trafficking under steady-state conditions and after CXCR4 antagonist (plerixafor/AMD3100) mobilization. SIVS utilizes sequential infusions of fluorescent anti-CD45 antibodies to label circulating leukocytes, enabling the quantification of blood residence and tissue migration without physiological disruption. Under steady-state, circulating CD34⁺ HSPCs were rare, persisted in blood for less than 48 hours, and minimally re-entered bone marrow (BM) niches. Among extramedullary tissues, the spleen showed the highest HSPC turnover, whereas the thymus and lymph nodes contributed minimally. Plerixafor mobilization induced a rapid, transient surge in circulating CD34⁺ cells that exhibited longer bloodstream persistence and slower egress than steady-state cells, with limited BM rehoming within 12 hours. Bulk RNA-seq revealed distinct transcriptional profiles linked to trafficking behavior. BM-resident HSPCs were enriched for proliferation and stemness signatures, whereas continuously circulating cells showed reduced stemness and enhanced inflammatory signatures. AMD3100-mobilized cells displayed an intermediate transcriptional profile. Together, these findings provide a spatiotemporal framework for understanding HSPC circulation and homing in a translationally relevant non-human primate model. These mechanistic insights can guide the optimization of stem cell mobilization, collection, and engraftment strategies in clinical transplantation and gene therapy.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: